EU Clinical Trial 2016-004463-39

Influence on cough and airway symptoms by oral capsaicin (capscium oleoresin ) – a phase II, randomised, placebo-controlled clinical study in patients with chronic idiopathic cough  Mar 6, 2019

Main objective of the trial: To establish whether an oral intake of capsicum oleoresin; capsaicinoids expressed as 0,4 mg capsaicin (C18H27N03; M, 305.4) (from chili extract) can desensitise the cough reflex and improve unexplained coughing.


Capsicum oleoresin evami2

JSON preview

Similar records


Source:  EMA Last updated:  May 30, 2019

From, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.